Pretargeting immunotherapy: a novel treatment approach for systemic amyloidosis.

Wall, Jonathan S; Foster, James S; Martin, Emily B; Kennel, Stephen J

Wall, Jonathan S; Foster, James S; Martin, Emily B; Kennel, Stephen J.

Afiliación

Wall JS; Departments of Medicine & Radiology, University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA.
Foster JS; Department of Medicine, University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA.
Martin EB; Department of Medicine, University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA.
Kennel SJ; Departments of Medicine & Radiology, University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville, TN 37920, USA.

Pharm Pat Anal ; 6(5): 215-223, 2017 Sep.

Article en En | MEDLINE | ID: mdl-28825509

Asunto(s)

Inmunoterapia; Amiloide; Amiloidosis; Humanos; Mieloma Múltiple; Péptidos

Palabras clave

111F4; amyloidosis; antibodies; immunotherapy; p5+14; peptides; peptope; pretargeting

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Límite: Humans Idioma: En Revista: Pharm Pat Anal Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google